Congenital Disorders of Glycosylation
Gene: GALNT3
GALNT3 is one of several enzymes that catalyze the reaction UDP-GalNAc + polypeptide-(Ser/Thr)-OH to GalNAc-alpha-O-Ser/Thr-polypeptide + UDP, thereby initiating O-glycosylation of serine and threonine residues on an array of glycoproteins.
Hyperphosphatemic familial tumoral calcinosis is a rare autosomal recessive metabolic disorder characterised by the progressive deposition of basic calcium phosphate crystals in periarticular spaces, soft tissues, and sometimes bone. More than 5 unrelated families reported.Created: 21 Dec 2020, 7:32 a.m. | Last Modified: 21 Dec 2020, 7:32 a.m.
Panel Version: 0.343
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Tumoral calcinosis, hyperphosphatemic, familial, 1, MIM# 211900
Publications
Gene: galnt3 has been classified as Green List (High Evidence).
Phenotypes for gene: GALNT3 were changed from to Tumoral calcinosis, hyperphosphatemic, familial, 1, MIM# 211900
Publications for gene: GALNT3 were set to
Mode of inheritance for gene: GALNT3 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal
gene: GALNT3 was added gene: GALNT3 was added to Congenital Disorders of Glycosylation_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: GALNT3 was set to Unknown